Ainos, Inc. (AIMD)
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
$3.89M
Mr. Chun-Hsien Tsai
34.00
San Diego, CA
Jan 08, 2021
-0.15
$-3.21
1.40
1.48
-23,663.55%
-0.20
-0.00
0.15
59.39
1.45
-43.36%
-64.53%
Similar stocks (9)
Artivion, Inc.
AORT
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
Anika Therapeutics, Inc.
ANIK
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Movano Inc.
MOVE
STRATA Skin Sciences, Inc.
SSKN
Tenon Medical, Inc.
TNON
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
Artivion, Inc.
AORT
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
Anika Therapeutics, Inc.
ANIK
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Movano Inc.
MOVE
STRATA Skin Sciences, Inc.
SSKN
Tenon Medical, Inc.
TNON
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%